VISUfarma
Manufacturing · Netherlands · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Joop Geesinkweg 601, Amsterdam- Duivendr...Phone Number
+31 202362200Website
www.visufarma.comRevenue
$50.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About VISUfarma
VISUfarma is dedicated to providing a comprehensive range of high-quality products and solutions for various ocular health issues, including dry eye disease, glaucoma, ocular allergies, and eyelid hygiene. Their offerings include ocular lubricants, food supplements, and treatments for conditions like blepharitis and meibomian gland dysfunction. The company targets healthcare professionals and patients seeking effective management of eye health conditions. Additionally, VISUfarma engages in educational initiatives such as webinars to enhance knowledge in ocular health.Explore more
VISUfarma Org Chart
TA
Medical Sales Representative
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VISUfarma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if VISUfarma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at VISUfarma
VISUfarma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when VISUfarma launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on VISUfarma recently announced quarterly report
Click to see if VISUfarma had a recent Job posting/layoffs
Check out if VISUfarma is spiking on competitors!
Funding: Get notified immidiatlly once VISUfarma has new funding data
Recommended Actions
Find VP level buyers at VISUfarma
Find 3 more new buyers
Company Profile Activity
Activity Insights
VISUfarma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VISUfarma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VISUfarma.
VISUfarma Tech Stack
A closer look at the technologies used by VISUfarma
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Event
Events
Event
will be attending the 100% Optical 2023 conference as an exhibitor. The event will occur from February 25 to February 27, 2023.
Project
A high-level source in human resources has indicated that the organization has completed initiatives related to employee training within the last nine months.
Training, Employee Relations
Project
VISUfarma News & Media
Lupin Completes Acquisition of VISUfarma
MUMBAI, India and LONDON and ROME and ZUG, Switzerland, April 2, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). The acquisition represents a significant milestone in Lupin's strategy to expand its specialty care portfolio and stLupin Completes Acquisition of VISUfarma
MUMBAI, India and LONDON and ROME and ZUG, Switzerland, April 2, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European...Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition of VISUfarma B.V. (VISUfarma), a portfolio company of global healthcare specialist investor GHO Capital Partners LLP (GHO). The acquisition of VISUfarma, with its broad portfolio of innovative eye healt
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VISUfarma
Sign Up For FreeTo access detailed company insights
VISUfarma is dedicated to providing a comprehensive range of high-quality products and solutions for various ocular health issues, including dry eye disease, glaucoma, ocular allergies, and eyelid hygiene. Their offerings include ocular lubricants, food supplements, and treatments for conditions like blepharitis and meibomian gland dysfunction. The... Read More
